Head of Preclinical Drug Development @ (June 2020 - December 2022)
Director Global Integration and Separation @ Novartis International AG (September 2017 - June 2020)
Director, Portfolio Management, Global Drug Development @ (October 2016 - August 2017)
Associate Director, Portfolio Analytics @ (October 2012 - September 2016)
Senior Lab Head: Department of Drug Metabolism and Pharmacokinetics @ (January 2008 - September 2012)
Staff Scientist @ (January 1991 - January 2008)
Kyle Landskroner Education
NC State College of Veterinary Medicine
PhD, Comparative Biomedical Science: Pharmacology
2001-2005
University of Oregon
BS (Biochemistry)
1986-1991
Kyle Landskroner Summary
Kyle Landskroner, based in Basel, BS, CH, is currently a Chief Scientific Officer at AZAFAROS B.V.. Kyle Landskroner brings experience from previous roles at AZAFAROS B.V., Novartis International AG and Novartis. Kyle Landskroner holds a 2001 - 2005 PhD, Comparative Biomedical Science: Pharmacology @ NC State College of Veterinary Medicine. Kyle Landskroner has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Kyle Landskroner?
Find contact details for 700 million professionals.